Exelixis, Inc. (EXEL)

43.63 -0.20 (-0.46%) USD  |  NASDAQ  |  Jan 02, 10:13
More

Exelixis Change in Receivables (Quarterly)

Change in Receivables (Quarterly) Chart

View Change in Receivables (Quarterly) for EXEL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Change in Receivables (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Change in Receivables (Quarterly) Range, Past 5 Years

View Change in Receivables (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Change in Receivables (Quarterly) Benchmarks

View Change in Receivables (Quarterly) Benchmarks
Start Trial
Vanda Pharmaceuticals, Inc. Upgrade
ADMA Biologics, Inc. Upgrade
Aldeyra Therapeutics, Inc. --
Neurocrine Biosciences, Inc. Upgrade
Axsome Therapeutics, Inc. Upgrade